Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Roche presents new Raf kinase B inhibitors

July 12, 2022

PLK4 inhibitor with promising preclinical activity against TRIM37-amplified breast cancer

July 12, 2022

Sunshine Lake Pharma synthesizes new GTPase KRAS inhibitors

July 11, 2022

XuanZhu Pharma identifies new AhR antagonists

July 11, 2022

Nanjing Shijiang Medicine Technology patents new compounds for cancer

July 11, 2022

Novel murine model of NASH-driven HCC developed

July 11, 2022

DS-17701585, EP300/CBP inhibitor with efficacy in lung squamous cell carcinoma xenograft

July 8, 2022

Explant glioblastoma model may allow early precision treatment of patients

July 8, 2022

BRCA1 methylation, mutation portend different response to chemotherapy

July 7, 2022

DAP3 and DELE1 impact chemosensitization of CRC cells

July 7, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...